59 Our data indicated a slight trend toward a reduction in the incidence of bronchospasm in the beta-blocker group, with a 48% lower relative risk of this complication in patients who received beta-blocker compared to those who received placebo.
← all excerpts
Respiratory outcomes of adrenergic beta-antagonists in patients undergoing tracheal extubation: a systematic review and meta-analysis of randomized controlled trials.
1
—
—